Take the chance to hear Shalinia Andersson, who is Head of Oligonucleotide Discovery at AstraZeneca, when she is invited to speak at Sahlgrenska Academy Science Seminars this Thursday. She will talk about the development of oligonucleotide drugs and the possibilities with OligoNova Hub. At this national technology platform Swedish researchers will be able to further develop their academic discoveries towards new oligonucleotide drugs, based on short DNA or RNA molecules. OligoNova Hub is funded by the Knut and Alice Wallenberg Foundation, SciLifeLab and the University of Gothenburg.
Sahlgrenska akademins nyheter
En personlig död (A Personal Death) – a chance to win Björn Fagerberg’s new book
She is doing her residency in the US with a medical degree from Gothenburg
Alba Corell reports from a high-level brain tumor meeting
From South Africa to Sweden: Collaborative Research Efforts Improving Pregnant Women’s Health
Sara Bjursten and Anna Wenger are the recipients of the Assar Gabrielsson Prize 2024
A full day for PhD students focused on mental health
Kaj Blennow ranked highest in Sweden in neuroscience
Linda Wass is doing a postdoc at Stanford with ALF funding
Karin Nilsson wrote the Thesis of the Year at Sahlgrenska Academy in 2023
